FINWIRES · TerminalLIVE
FINWIRES

Nyrada Completes Cardioprotection Pilot Study for Lead Drug Candidate

By

Nyrada (ASX:NYR) completed a preclinical cardioprotection pilot study that confirmed the feasibility and tolerability of the planned subcutaneous dosing for its Xolatryp lead drug candidate in combination with doxorubicin, according to a Wednesday filing with the Australian bourse.

The pilot study aimed to evaluate whether Xolatryp can provide a cardioprotective role in anthracycline chemotherapy, to reduce cardiotoxicity without jeopardizing anti-tumor activity, per the filing.

Preliminary biomarker data from the trial showed lower levels of a clinically relevant marker of cardiac injury relative to a control group, the company said.

The pilot study was not designed to show statistical significance for an efficacy readout, but it will inform the design of a larger cardiomyopathy study for which results are expected in the third quarter, Nyrada said.

The company's shares fell 6% in recent Wednesday trade.

Related Articles

Asia

Liaoning Port Slates June 22 Creditors' Meeting for Bankrupt Former Unit

Liaoning Port (HKG:2880, SHA:601880) said the first creditors' meeting for its former wholly owned subsidiary DCT Logistics has been scheduled for June 22 as part of its bankruptcy liquidation process, according to a Tuesday Hong Kong bourse filing.The port operator said it has lost control of DCT Logistics, which is no longer consolidated into its financial statements.The Dalian Economic and Technological Development Zone People's Court accepted DCT Logistics' bankruptcy liquidation application in December 2025 and appointed a bankruptcy administrator.The bankruptcy administrator has completed the handover of assets and records and is conducting an asset inventory, financial audit, and valuation.The company said the proceedings are not expected to have a material adverse effect on its financial position or operating results.

$HKG:2880$SHA:601880
Asia

ESR REIT Sets Up SG$2 Billion Bond Program

ESR REIT (SGX:9A4U) established a SG$2 billion Euro medium-term securities program, according to a Tuesday Singapore bourse filing.Shares of the REIT were down under 1% in Wednesday trading.The REIT named Oversea-Chinese Banking Corp. (OCBC) as the arranger and initial dealer of the program.Net proceeds from each issue will be used to refinance existing borrowings, refinance acquisitions, and meet general working capital needs.The REIT has secured the Singaporean bourse's in-principle approval for the program.

$SGX:9A4U
Asia

Vietnam FDI Rises 9.6% in January-May

Vietnam's foreign direct investment rose 9.6% year over year to about $9.75 billion in the first five months of 2026, the National Statistics Office reported Wednesday.FDI grew from $7.40 billion in the first four months and exceeded analysts' forecast of $9.1 billion, according to Trading Economics data.Total registered foreign investment in the country as of the end of May increased 35% year over year to $24.8 billion.

$^HNX$^HOSE